内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Macrae Sandy. Director active across 1 company, notably Sangamo Therapeutics, INC. Cumulatively, 20 filings have been recorded. History available since 25 February 2022. The latest transaction was filed on 24 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Macrae Sandy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
5,291 股@ US$0.47250.2% 占其流量Common StockSEC:0001675687-26-000004:0
102,950 股@ US$0.39853.4% 占其流量Common StockSEC:0001675687-26-000002:0
7,488 股@ US$0.41660.3% 占其流量Common StockSEC:0001675687-25-000008:0
126,950 股@ US$0.667.2% 占其流量Common StockSEC:0001675687-25-000006:0
7,488 股@ US$0.58630.4% 占其流量Common StockSEC:0001415889-25-023081:0
126,950 股@ US$0.47985.6% 占其流量Common StockSEC:0001415889-25-020245:0
7,488 股@ US$0.47330.3% 占其流量Common StockSEC:0001415889-25-014692:0
126,950 股@ US$0.77639.9% 占其流量Common StockSEC:0001415889-25-011283:0
7,488 股@ US$1.000.8% 占其流量Common StockSEC:0001415889-25-005704:0
412,584 股@ US$1.1552.2% 占其流量Common StockSEC:0001415889-25-002018:0
7,473 股@ US$1.881.5% 占其流量Common StockSEC:0001415889-24-027702:0
5,261 股@ US$0.860.5% 占其流量Common StockSEC:0001415889-24-022306:0
5,261 股@ US$0.600.3% 占其流量Common StockSEC:0001415889-24-014775:0
16,115 股@ US$1.131.9% 占其流量Common StockSEC:0001415889-24-005546:0
2,000,000 股0Common StockSEC:0001415889-24-001754:0
10,411 股@ US$0.38210.4% 占其流量Common StockSEC:0001209191-23-056786:0
10,411 股@ US$0.770.8% 占其流量Common StockSEC:0001209191-23-047582:0
10,411 股@ US$1.331.5% 占其流量Common StockSEC:0001209191-23-032903:0
157,300 股0Common StockSEC:0001209191-23-016387:0
49,890 股@ US$5.9025.2% 占其流量Common StockSEC:0001209191-22-014164:0
About Macrae Sandy
Macrae Sandy is a declarant linked to Sangamo Therapeutics, INC, where he is PRESIDENT, CEO AND DIRECTOR. The record shows 20 filings in total, and the 20 sampled filings cover the period from 2022-03-01 to 2026-02-26, with the transaction nature indicated as tax withholding.